1: Chen CH, Hu TH, Huang TC, Chen YL, Chen YR, Cheng CC, Chen CT. Delineation of G-Quadruplex Alkylation Sites Mediated by 3,6-Bis(1-methyl-4-vinylpyridinium iodide)carbazole-Aniline Mustard Conjugates. Chemistry. 2015 Nov 23;21(48):17379-90. doi: 10.1002/chem.201502595. Epub 2015 Oct 13. PubMed PMID: 26769627.
2: Fedeles BI, Zhu AY, Young KS, Hillier SM, Proffitt KD, Essigmann JM, Croy RG. Chemical genetics analysis of an aniline mustard anticancer agent reveals complex I of the electron transport chain as a target. J Biol Chem. 2011 Sep 30;286(39):33910-20. doi: 10.1074/jbc.M111.278390. Epub 2011 Aug 10. PubMed PMID: 21832047; PubMed Central PMCID: PMC3190774.
3: Benckhuysen C, Ter Hart HG, Van Dijk PJ. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):567-74. PubMed PMID: 6788369.
4: McClean S, Costelloe C, Denny WA, Searcey M, Wakelin LP. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards. Anticancer Drug Des. 1999 Jun;14(3):187-204. PubMed PMID: 10500495.
5: Gourdie TA, Valu KK, Gravatt GL, Boritzki TJ, Baguley BC, Wakelin LP, Wilson WR, Woodgate PD, Denny WA. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard. J Med Chem. 1990 Apr;33(4):1177-86. PubMed PMID: 2319563.
6: Panthananickal A, Hansch C, Leo A. Structure-activity relationship of aniline mustards acting against B-16 melanoma in mice. J Med Chem. 1979 Oct;22(10):1267-9. PubMed PMID: 513075.
7: Hansch C, Telzer BR, Zhang L. Comparative QSAR in toxicology: examples from teratology and cancer chemotherapy of aniline mustards. Crit Rev Toxicol. 1995;25(1):67-89. Review. PubMed PMID: 7734060.
8: Leo A, Panthananickal A, Hansch C, Theiss J, Shimkin M, Andrews AW. A comparison of mutagenic and carcinogenic activities of aniline mustards. J Med Chem. 1981 Jul;24(7):859-64. PubMed PMID: 7277394.
9: Trafalis D, Geromichalou E, Dalezis P, Nikoleousakos N, Sarli V. Synthesis and evaluation of new steroidal lactam conjugates with aniline mustards as potential antileukemic therapeutics. Steroids. 2016 Nov;115:1-8. doi: 10.1016/j.steroids.2016.07.009. Epub 2016 Jul 26. PubMed PMID: 27473822.
10: Gravatt GL, Baguley BC, Wilson WR, Denny WA. DNA-directed alkylating agents. 4. 4-anilinoquinoline-based minor groove directed aniline mustards. J Med Chem. 1991 May;34(5):1552-60. PubMed PMID: 2033580.
11: Fan JY, Valu KK, Woodgate PD, Baguley BC, Denny WA. Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity. Anticancer Drug Des. 1997 Apr;12(3):181-203. PubMed PMID: 9154110.
12: Gamcsik MP, Millis KK, Hamill TG. Kinetics of the conjugation of aniline mustards with glutathione and thiosulfate. Chem Biol Interact. 1997 Jun 6;105(1):35-52. PubMed PMID: 9233374.
13: Chipman JK, Hirom PC, Millburn P. Biliary excretion and enterohepatic circulation of aniline mustard metabolites in the rat and the rabbit. Biochem Pharmacol. 1980 May 1;29(9):1299-301. PubMed PMID: 7397013.
14: Kapuriya N, Kapuriya K, Zhang X, Chou TC, Kakadiya R, Wu YT, Tsai TH, Chen YT, Lee TC, Shah A, Naliapara Y, Su TL. Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage. Bioorg Med Chem. 2008 May 15;16(10):5413-23. doi: 10.1016/j.bmc.2008.04.024. Epub 2008 Apr 15. PubMed PMID: 18450456.
15: Prakash AS, Denny WA, Wakelin LP. Differences in sequence selectivity of DNA alkylation by isomeric intercalating aniline mustards. Chem Biol Interact. 1990;76(2):241-8. PubMed PMID: 2225231.
16: Young CW, Yagoda A, Bittar ES, Smith SW, Grabstald H, Whitmore W. Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell beta-glucuronidase activity. Cancer. 1976 Nov;38(5):1887-95. PubMed PMID: 991104.
17: Schneider MR, Schuderer ML. Cytotoxic estrogens: anilin mustard linked 1,1,2-triphenylbut-1-enes with mammary tumor inhibiting activity. Arch Pharm (Weinheim). 1989 Jan;322(1):59-62. PubMed PMID: 2730288.
18: Boritzki TJ, Palmer BD, Coddington JM, Denny WA. Identification of the major lesion from the reaction of an acridine-targeted aniline mustard with DNA as an adenine N1 adduct. Chem Res Toxicol. 1994 Jan-Feb;7(1):41-6. PubMed PMID: 8155823.
19: Gourdie TA, Prakash AS, Wakelin LP, Woodgate PD, Denny WA. Synthesis and evaluation of DNA-targeted spatially separated bis(aniline mustards) as potential alkylating agents with enhanced DNA cross-linking capability. J Med Chem. 1991 Jan;34(1):240-8. PubMed PMID: 1992124.
20: Palmer BD, Wilson WR, Cliffe S, Denny WA. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. J Med Chem. 1992 Aug 21;35(17):3214-22. PubMed PMID: 1507207.